|
GLP-1 (7-37) Acetate
|
|
Product Name GLP-1 (7-37) Acetate Sequence His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-GlyCas No. 106612-94-6Molecula
|
| |
Glucagon(1-29)(Human)
|
|
Product Name Glucagon(1-29)(Human) Sequence H-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-OHCas No. 16941-32-5Molecular For
|
| |
Gonadorelin Acetate
|
|
Product Name Gonadorelin Acetate Sequence Glp-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2Cas No. 71447-49-9Molecular Formula C55H75N17O13Molecular Weight 1182.3Purity (HPLC) 98.0%min.Appearance?
|
|
|
Gonadorelin Acetate
|
|
Product Name Gonadorelin Acetate Sequence Glp-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2Cas No. 71447-49-9Molecular Formula C55H75N17O13Molecular Weight 1182.3Purity (HPLC) 98.0%min.Appearance?
|
| |
GRF(human)Acetate
|
|
Product Name GRF(human)Acetate Sequence Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-G
|
| |
GRF(human)Acetate
|
|
Product Name GRF(human)Acetate Sequence Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Ar
|
|
|
Hexarelin
|
|
Product Name Hexarelin Sequence Cas No. 140703-51-1 Molecular Formula C47H58N12O6 Molecular Weight 887.0 Appearance White Powder IR spectrum
|
| |
HGH 176-191
|
|
HGH 176-191H 176-191 2mg/vial1.product descroption:The H Fragment is a modified form of amino acids 176-191 at the C-terminal region of the human growth hormone (HGH). Studies have s
|
| |
HGH 176-191
|
|
HGH 176-191H 176-191 2mg/vial1.product descroption:The H Fragment is a modified form of amino acids 176-191 at the C-terminal region of the human growth hormone (HGH). Studies have shown
|
|